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A B S T R A C T  
 
The Resonance Ionization Laser Ion Source (RILIS) has become an essential feature of many radioactive ion beam facilities worldwide since it offers an 
unmatched combination of efficiency and selectivity in the production of ion beams of many different chemical elements. In 2019, the laser ion source setup 
MELISSA is going to be established at the CERN-MEDICIS facility, based on the experience of the workgroup LARISSA of the University Mainz and CERN 
ISOLDE RILIS team. The purpose is to enhance the capability of the radioactive ion beam supply for end users by optimizing the yield and the purity of the 
final product. In this article, the blueprint of the laser ion source, as well as the key aspects of its development and operation are presented.  
 




The CERN-MEDICIS radioactive ion beam facility aims for the 
production of innovative medical radioisotopes [1]. It is foreseen to 
use two production routes. The first one implies the use of the 
1.4 GeV proton beam coming from the CERN Proton-Synchrotron 
for irradiation of the target material at one of the ISOLDE target 
stations, with subsequent radionuclide extraction at the dedicated 
CERN-MEDICIS mass separator. The targets are transferred to the 
separator bunker from their irradiation point using the specially 
developed mono rail system «MONTRAC». The “off-line” nature 
of the extraction process almost excludes a possibility to produce 
radionuclides with a half-life less than minutes, but the transfer time 
of the target unit to the mass separator is short enough for a regular 
production of isotopes having a half-life above one hour, which 
corresponds to most radioisotopes of medical interest. 
The second production route is based on the radionuclide 
extraction from targets pre-irradiated and provided by external 
institutions, such as nuclear reactors, medical accelerators and 
cyclotrons, and nuclear waste depositaries. This additional 
operation mode of MEDICIS is particularly important during the 
periods of unavailability of the CERN accelerator complex, thereby 
enabling a radionuclide supply to the user even during the CERN 
long-shutdown maintenance periods, expanding capabilities in 
production of useful radioisotopes [2]. 
The MEDICIS mass separator uses a conventional dipole 
electromagnet for mass selection, which requires a work substance 
to be in the form of a mono-energetic ion beam. Traditionally, 
surface ionization or plasma ionization methods are used, and all 
ions are extracted at the same energy (30-60 keV). However, these 
ion sources offer limited selectivity, and thus usually give rise to 
undesired isobaric contamination. For many areas of radionuclide 
applications, the chemical and isotopic purity is of highest 
importance. The presence of significant or dominant isobaric or 
isotopic impurities is particularly not acceptable for use in the 
personalized nuclear medicine. The impurities not only reduce the 
effectiveness of a treatment, but may cause unintended irradiation 
as well as a contamination of healthy tissues of a living being with 
other radionuclides. Almost independent of the production 
mechanism, achieving the required purity requires various 
individual steps, often including element-specific radiochemistry, 
procedure that can significantly increase the total production time, 
leading to a reduction in the specific activity of short-lived species. 
Today the resonance ionization laser ion source (RILIS) 
technique is successfully used at the majority of radioactive ion 
beam facilities worldwide for efficient and selective ionization of a 
work substance [3]. The working principle is multi-step resonance 
photo- excitation and subsequent ionization of atoms of the desired 
chemical element. The combination of the conventional 
electromagnetic mass separation and the laser resonance ionization 
allows to extract selectively ion beams of a desired radionuclide. 
Moreover, the laser ion source achieves a high ionization efficiency 
(typically more than 10%) for numerous elements, comparable, if 
not superior, to that of the plasma ionization approach.  
A laser ion source for the MEDICIS facility was therefore 
foreseen as a future advance of MEDICIS during the initial design 
and construction of the facility. As a core of the future setup, an all-
solid-state laser system was chosen, jointly designed with the 
Johannes Gutenberg University Mainz. It is based on solid-state 
titanium:sapphire lasers, which have proven to be sufficiently 
reliable and flexible for continuous operation at ISOL facilities. The 
layout, configuration and current status of the MEDICIS Laser Ion 
Source Setup At CERN, named MELISSA, is described here. 
2. MEDICIS Laser Ion Source Setup – MELISSA 
2.1. Laser laboratory design 
Since CERN-MEDICIS is a radioactive facility, the laboratory 
equipment is contained within restricted areas, which must fulfill 
special requirements in accordance with the radiation safety 
regulation. To allow access to and operation of the laser laboratory 
at any time, and to avoid unnecessary dose uptake for the laser 
operators, it was decided to build a room, separated from the 
radiochemical laboratory and the mass separator bunker. 
Fig. 1 illustrates a schematic of the upcoming laser laboratory. 
It is divided into three rooms: a dressing room (buffer laser-safe 
entrance area); the main room with the optical tables, where the 
laser system is located; a supplementary room for closed-circuit 
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Fig. 1. Overview of the MELISSA laser laboratory and the MEDICIS mass separator layout. 
 
laser chillers, to minimize the heat emission and noise stress into 
the main laser laboratory. The lasers in the room are interlocked 
against non-granted access, and the laboratory is physically isolated 
from other MEDICIS environments. A dedicated air conditioning 
and ventilation system was installed to guarantee a stable 
performance of the laser. At the point of the laser beam launch 
system towards the separator, lasers will pass through a window, 
which eliminates air flow between the laboratory and the radiation-
controlled areas. The laser beam path from the laser laboratory to 
the separator bunker is enclosed to avoid any laser hazards for 
MEDICIS operators or users. Therefore, the laser laboratory is the 
only area where laser hazards exist during normal operation. 
The optical path distance from the laser laboratory to the target 
unit is 13 meters. As the separator bunker is a radioactive area, and 
therefore inaccessible during normal operation mode, a method of 
the reliable overlap of laser beams in the ion source was established, 
without the need to open up the laser shielding or physically access 
the target bunker. A pair of reference beams are produced by the 
Fresnel reflections from each surface of the wedged (3 arcmin) 
reference window (Fig. 1), located at ~8 m distance from the target. 
These will be directed back to the laser laboratory to be distributed 
in a dedicated ‘virtual ion source’ reference area. At this location, 
laser beam monitoring and stabilization systems, similar to one 
developed at the ISOLDE-RILIS [4], will be established. The laser 
path to the target unit can be also used to observe and control the 
thermal behavior in the ion source during the extraction process via 
an optical pyrometer, installed in the laser laboratory. Eventually, 
the MELISSA installation will be integrated into the control system 
of the MEDICIS facility, with a long-term goal of becoming a 
«turn-key» system, where lasers will be automatically tuned to 
required wavelengths and aligned into the ion source in accordance 
with greatly reduced laser-operator dependence compared to that of 
the current ISOLDE-RILIS system. 
2.2. Laser system development 
To minimize the laser setup, operation and maintenance time, 
which introduce some constraints on the production planning, it is 
foreseen for MELISSA to use highly reliable wide-range tunable 
pulsed titanium:sapphire lasers constructed by the LARISSA group 
of the University Mainz, pumped by commercial frequency doubled 
Nd:YAG lasers. The use of the all-solid-state laser system instead 
of dye lasers allows performing the ionization and collection of 
radioisotopes without interruptions for changing of dye solutions. It 
also prevents handling of chemically hazardous substances by laser 
operators, and simplifies safety requirements for the laser 
laboratory. 
As can be seen from Fig. 1, each titanium:sapphire laser will be 
pumped by a dedicated Nd:YAG laser. A multi-channel pulse delay 
generator will trigger the pump lasers, and enable optimization of 
the laser pulse synchronization with nanosecond precision, what is 
essential for achieving the maximum ionization efficiency. Pumped 
with 15 W at 532 nm with a repetition rate of 10 kHz, the 
titanium:sapphire laser can emit up to 5 W output power using the 
standard “Z” cavity, with a spectral linewidth and pulse length of 
approximately 5 GHz and 40 ns, respectively [5]. The fundamental 
emission range spans from 690 to 960 nm. The frequency 
conversion (FCU) of laser radiation to second, third, or fourth 
harmonics (SHG, THG, FHG), passing the laser beam through non-
linear crystals (bismuth barium borate, BiBO, or beta-barium 
borate, BBO), extends the wavelength tuning range to the blue and 
UV regions of the optical spectrum. 
To reduce the time required for changing the ionization scheme, 
the most advanced automated grating-tuned titanium:sapphire laser 
with intra-cavity SHG (Fig. 2) was developed [6]. Principally, the 
intra-cavity SHG with a single non-linear crystal can cover a 
wavelength range i.e. from 375 nm to 475 nm. The output power 
with up to 1.5 W is lower, compared to the standard cavity, but still 
high enough for ionization application: as shown in [7], ionization 
schemes using transitions in this wavelength range could be 
identified with saturation threshold typically below 100 mW. 
Operated by a dedicated software, controlling the grating and non-
linear crystal angles in relation to output wavelength and power, 
this laser allows a rapid and automated switching between required 
wavelengths. 
2.3. Laser resonance ionization spectroscopy 
Today laser resonance ionization schemes almost for all 
metallic elements are available in literature [3], [8], [9]. Because of 
the historical development of laser technologies, the majority of 
known schemes are optimized to the emission range of various dye 
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lasers. The use of titanium:sapphire lasers requires additional 
investigation of atomic spectra of elements, if the existing 
transitions are not in their working range. 
The characterization of a suitable multi-step laser resonance 
ionization scheme for a desired element is necessary to achieve the 
optimal ionization efficiency along with a sufficient chemical and 
isotopic purity, and reliability of the production process. Therefore, 
for chemical elements of interest to MEDICIS [1], laser resonance 
ionization spectroscopy studies were undertaken to define laser 
ionization schemes, suitable for the emission range of 
titanium:sapphire lasers. This work is focused on rare-earth 
elements, because many medically relevant isotopes, being 
promising for the theranostics approach [10], are found within this 
group. Several lanthanides, such as Dy, Ho, and Yb, were already 
investigated [11], [12]. Results on Lu are published in [7]. New 
results on Er [2], Tb and Nd are currently evaluated, and will be 
reported in forthcoming publications. 
It was observed that many lanthanides can be easily and 
efficiently ionized by two-step excitation schemes with transitions 
in the blue spectral range (350-475 nm). With the use of two 
automated grating-tuned titanium:sapphire lasers with intra-cavity 
SHG, a switching-time of less than a minute between different 
ionization schemes has been demonstrated. This feature is desirable 
for fast extraction of different short-lived radionuclides from an 
irradiated target, expanding the variety of producing radioisotopes.  
 
 
Fig. 2. Schematic layout of an automated grating tuned titanium:sapphire laser 
with intracavity frequency doubling 
3. Conclusions and outlook 
In 2019, CERN-MEDICIS will install and commission the laser 
ion source setup MELISSA. The use of element selective ionization 
will improve the ion beam purity of extracted radioisotopes. Several 
laser resonance excitation schemes for lanthanides of medical 
interest have already been developed with efficiencies more than 
50 %, measured at the Mainz RISIKO mass separator. These 
schemes will be used to produce at the MEDICIS facility the first 
laser ionized samples of medical radionuclides (approx. in April, 
2019), and will be reported in the upcoming PhD theses of Vadim 
Gadelshin and Roberto Formento-Cavaier. 
Because of the second long shutdown of the CERN accelerator 
complex (LS2), which will continue until 2021, MEDICIS will only 
be supplied with externally irradiated targets. Their place of origin 
and subsequent operation may be quite different from those of the 
CERN on-site irradiation. Externally irradiated targets may arrive 
in a variety of chemical forms and conditions. Thus, the ion source 
chemistry and physics need to be specially investigated to achieve 
the best production results in each individual case. 
The radionuclide extraction from externally irradiated targets, 
e.g. for Tb radioisotope production by proton irradiation of 
gadolinium targets, can be accompanied by a strong isobaric 
contamination on the desired mass. The implementation of the laser 
ion source may enable isotope extraction at a lower temperature, 
decreasing the undesired surface ionization of contaminants. 
Optimizing the configuration of the ion source and the design of the 
target unit, as well as the operational procedure, isobaric 
contaminants can be additionally suppressed, leading to a high 
purity of the products.  
It is also necessary to continue the development work on 
extension of the wavelength range available from the 
titanium:sapphire lasers, as well as on enhancement of the output 
power; towards the design of a "turn-key" laser system, aiming for 
an automatically aligned and optimized laser system for a pre-
defined ionization scheme of a desired element. By achieving a 
higher efficiency and enabling the direct ionization of a required 
isotope, rather than waiting for the decay of short- or long-lived 
contaminants, the overall production time will be reduced in many 
cases. It will enlarge the variety of producible medical 
radionuclides, delivering with a high specific activity. 
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